<DOC>
	<DOCNO>NCT01342796</DOCNO>
	<brief_summary>This study aim evaluate immunogenicity , mean cell mediate immunity ( CMI ) hemagglutination inhibition ( HI ) assay , also safety MF59C.1-adjuvanted subunit influenza vaccine compare conventional subunit vaccine previously unvaccinated child age 6 &lt; 36 month .</brief_summary>
	<brief_title>Humoral Cell Mediated Immunity Safety MF59C.1-adjuvanted Subunit Influenza Vaccine Conventional Subunit Influenza Vaccine Previously Unvaccinated Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>MF59 oil emulsion</mesh_term>
	<criteria>Male female previously unvaccinated healthy child age 6 &lt; 36 month . Any known suspected impairment immune system , serious disease . Any subject receive licensed vaccine within 2 week ( inactivated vaccine ) 4 week ( live vaccine ) prior enrollment study . Individuals influenza vaccine document suspected influenza disease prior day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Cell mediate immunity</keyword>
	<keyword>cell mediate immune response</keyword>
	<keyword>Children</keyword>
	<keyword>adjuvanted</keyword>
</DOC>